Predicting HER2 status of breast cancer from basic pathology features: HER2 status of 1500 breast cancers determined by immunohistochemistry and flourescence In situ hybridisation with pathology correlation
- 1 March 2002
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (11), S52
- https://doi.org/10.1016/s0959-8049(02)80138-1